1h Free Analyst Time
The synthetic biology market is forecast to grow by USD 55.60 billion during 2023-2028, accelerating at a CAGR of 34.1% during the forecast period. The report on the synthetic biology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing applications leading to growing adoption of synthetic biology, growing investments in synthetic biology processes and techniques, and increasing demand for synthetic genes and synthetic cells.
The synthetic biology market is segmented as below:
By Application
- Healthcare
- Industrial
- Food and agriculture
- Others
By Product
- Oligonucleotides
- Enzymes
- Cloning technology kits
- Xeno-nucleic acids
- Chassis organism
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the synthetic biology market covers the following areas:
- Synthetic biology market sizing
- Synthetic biology market forecast
- Synthetic biology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global synthetic biology market: Agilent Technologies Inc., Algenol, Amyris Inc., CD Biosynsis, Codexis Inc, Creative Biogene, Danaher Corp., Eurofins Scientific SE, Genomatica Inc., GenScript Biotech Corp., Ginkgo Bioworks Holdings Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., Novozymes AS, Precigen Inc., Sanofi SA, Synthego Corp., Thermo Fisher Scientific Inc., and Twist Bioscience Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is evolving regulatory framework around synthetic biology."
According to the report, one of the major drivers for this market is the growing applications leading to growing adoption of synthetic biology.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Algenol
- Amyris Inc.
- CD Biosynsis
- Codexis Inc
- Creative Biogene
- Danaher Corp.
- Eurofins Scientific SE
- Genomatica Inc.
- GenScript Biotech Corp.
- Ginkgo Bioworks Holdings Inc.
- Illumina Inc.
- Merck KGaA
- New England Biolabs Inc.
- Novozymes AS
- Precigen Inc.
- Sanofi SA
- Synthego Corp.
- Thermo Fisher Scientific Inc.
- Twist Bioscience Corp.
